BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34958111)

  • 1. Tumor necrosis factor‑related apoptosis‑inducing ligand is a novel transcriptional target of runt‑related transcription factor 1.
    Yoshida T; Yamasaki K; Tadagaki K; Kuwahara Y; Matsumoto A; Sofovic AE; Kondo N; Sakai T; Okuda T
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.
    Barbetti V; Tusa I; Cipolleschi MG; Rovida E; Dello Sbarba P
    Cell Death Dis; 2013 Mar; 4(3):e536. PubMed ID: 23492767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
    Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
    Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G
    Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
    Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
    Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME; Hiebert SW
    Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
    Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
    J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.
    Ajore R; Kumar P; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2012 Mar; 13():11. PubMed ID: 22443175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.
    Goyama S; Schibler J; Cunningham L; Zhang Y; Rao Y; Nishimoto N; Nakagawa M; Olsson A; Wunderlich M; Link KA; Mizukawa B; Grimes HL; Kurokawa M; Liu PP; Huang G; Mulloy JC
    J Clin Invest; 2013 Sep; 123(9):3876-88. PubMed ID: 23979164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
    Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
    Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.
    Cao H; Cheng Y; You L; Qian J; Qian W
    Mol Med Rep; 2013 Jun; 7(6):1838-44. PubMed ID: 23620163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
    Ajore R; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
    Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
    Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.
    Kaur G; Jalagadugula G; Mao G; Rao AK
    Blood; 2010 Apr; 115(15):3128-35. PubMed ID: 20181616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
    Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
    J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.